600 patients66,869 observations120 daysLIVE

Patient P-01492

Synthetic patientNBL-101 · Day 112 · 35–44 · F · baseline S15Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Unstable
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
86%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S15
  2. Day 52 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 54 GI-04 recommendedGI Support Protocol GI-04
  4. Day 55 Patient declinedNot now
  5. Day 70 ME-01 recommendedMonitoring Escalation ME-01
  6. Day 71 Patient acceptedStarted ME-01 in the companion
  7. Day 74 Deterioration detected before clinical escalationMonitoring Escalation ME-01

What changed?

Trajectory began diverging from predicted response on Day 52.

Primary contributors, last 14 days
  • GI instability-15
  • Inflammatory activity-14
  • Nutritional resilience+4
  • Treatment adherence+2

What helped?

  • GI Support Protocol GI-04Day 54
    Declined by patient
  • Monitoring Escalation ME-01Day 70
    Result: deterioration detected before clinical escalation
LIFE OS recommendation
GI Support Protocol GI-04
92%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 83% showed improvement
  • median effect visible after 8 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
64.5/100
stable · -2.0 vs previous 14 d
Toxicity
Blood
60.2/100
improving · -2.8 vs previous 14 d
Sleep quality
Wearable
27.5/100
stable · -0.9 vs previous 14 d
Energy level
Daily log
2.2/10
stable · +0.0 vs previous 14 d
Stress level
Daily log
7.5/10
stable · -0.1 vs previous 14 d
Steps
Wearable
300
stable · +4 vs previous 14 d
Adherence
Companion
49.4 %
stable · -1.3 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards restoration · 21 from the failing basin, 71 from restoration.

Would help
  • GI-04 GI Support Protocol
    73% improved among 124 similar · onset 8 d · confidence 97%
  • NP-02 Dietary Support Protocol
    63% improved among 64 similar · onset 10 d · confidence 80%
  • SC-12 Supportive Compound
    76% improved among 51 similar · onset 6 d · confidence 80%
Would not help
  • Keep fibre low
    GI +4.5 next day on high-intake days · n 21
  • Keep histamine low
    GI +3.6 next day on high-intake days · n 21
  • Keep simple carbs low
    GI +3.5 next day on high-intake days · n 19
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Insoluble fibre
    +4.5detractor · 95%
  • Histamine load
    +3.6detractor · 95%
  • Simple carbohydrates
    +3.5detractor · 88%
  • Alcohol
    -1.9no signal · 35%
  • Spicy / capsaicin
    -0.8no signal · 15%
  • Dietary fat load
    -0.4no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 60
    • MicrobiomeBacteroides fragilis expansion
    • BloodInflammatory load index 63
    • WearableHRV 22 ms, trending down
  • Mucosal barrier integrity 50
    • DNAFUT2 non-secretor lowers mucosal fucosylation
    • Daily logGI symptom score 65 and rising
  • Butyrate / short-chain fatty acid production 45
    • MicrobiomeF. prausnitzii depleted
    • Daily logFibre intake low in recent food logs
  • Autonomic recovery 45
    • WearableResting HR 78 bpm
    • Wearable300 steps/day
  • Drug metabolism and exposure 20
    • BloodToxicity index 60
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • CYP2D6 Rapid metabolizer
    Expected exposure
Microbiome
Shannon diversity 2.1 · butyrate capacity 47/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
19 ms
Sleep
6.6 h
Steps
422
Resting HR
79 bpm
Daily log: GI score 65, nutritional resilience 27, adherence 49.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • A 15-minute walk after lunch
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0181343%S01NP-02no change40
P-0132733%S01GI-04improved56
P-0131027%S0157
P-0168827%S01GI-04improved40
P-0187723%S01CR-01improved67
P-0160417%S0171
P-0182117%S0158
P-0182317%S0157
P-0145228%S02GI-04improved46
P-0163528%S02GI-04improved49
P-0145923%S0251
P-0149817%S0256